Jim Tananbaum the CEO of Foresite Capital; improving healthcare with investments


The brain is one of the most intriguing parts of the human body. It interprets neurons and helps in almost running all of the body functions. Mindstrong Health is a start-up company funded by Foresite Capital, ARCH Venture Partners, Optimum Ventures, and One Mind Brain Impact Fund to a tune of $14 million in Series A funding. It is developing a neurological –focused device to monitor the patterns of interaction of smart-phone devices to the objective measure of brain activity. This serves to improve mental health care by developing a better intervention. For this to happen, Mindstrong CEO Paul Dagum appreciates the support he got from his investment partners who believed in his strategy to help with the brain research. One of the most notable investors is Jim Tananbaum. Visit ideamensch to know more.

Jim Tananbaum is a renowned investor who has taken an interest in investing in healthcare. In the last 25 years, he has spent his investments on health care franchises in all areas of healthcare economy. He was the co-founder of GelTex Pharmaceuticals which brought two drugs to market and was later purchased for a whopping $1.6 billion. He has also cofounded Theravance Inc. and Prospect Venture Partners. He is now the CEO of Foresite Capital. He has played a vital role in Foresite Capital investment organization structure and investment strategy making it manage approximately $1.1 billion worth of assets. Foresite Capital head office is in San Francisco with another office in New York. He has also invested in companies such as Jazz Pharmaceuticals, Amerigroup, and Amira Pharmaceuticals. He also sits on the board of directors with companies such as Tarsa Pharmaceuticals and Peloton Pharmaceuticals.

According to INC42, Jim is a well-educated guy. He holds an M.D. from Harvard Medical School and an MBA from Harvard Business School. Jim also has a B.S. and B.S.S.E. from Yale University. He has also served on the advisory boards to the Harvard-MIT HST program and Yale School of Engineering. He also has an M.S. from MIT. With such an impression is no wonder he has been on the Midas List of Top Tech Investors for three years and running. With these contributions to the healthcare, Jim Tananbaum is on the way to revolutionize healthcare in the world if he hasn’t yet already.

Reference: http://www.businesswire.com/news/home/20170418005997/en/Foresite-Capital-Announces-CEO-Jim-Tananbaum-Named